Ludmil Alexandrov

Associate Professor

University of California, San Diego

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Guilherme Mazzini

Assistant Professor of Surgery

Virginia Commonwealth University

UNITED STATES

View details

Nischalan Pillay

Associate Clinical Professor

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ludmil Alexandrov

Research Interests

Explore related searches

Contact this professor

Articles (13)

Enhanced precision in immunotherapy

Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides

Topography of mutational signatures in human cancer

Author Correction: DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer

DNA damage and somatic mutations in mammalian cells after irradiation with a nail polish dryer

Arsenic is a potent co-mutagen of ultraviolet light

AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas

An overview of mutational and copy number signatures in human cancer

Mechanisms of APOBEC3 mutagenesis in human cancer cells.

Examining clustered somatic mutations with SigProfilerClusters

Signatures of copy number alterations in human cancer.

Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.

Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.

Collaborators (2)

Guilherme Mazzini

Nischalan Pillay

Make your next move.